178 related articles for article (PubMed ID: 22546480)
1. Mitotane exhibits dual effects on steroidogenic enzymes gene transcription under basal and cAMP-stimulating microenvironments in NCI-H295 cells.
Lin CW; Chang YH; Pu HF
Toxicology; 2012 Aug; 298(1-3):14-23. PubMed ID: 22546480
[TBL] [Abstract][Full Text] [Related]
2. Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane.
van Koetsveld PM; Vitale G; Feelders RA; Waaijers M; Sprij-Mooij DM; de Krijger RR; Speel EJ; Hofland J; Lamberts SW; de Herder WW; Hofland LJ
Endocr Relat Cancer; 2013 Jun; 20(3):443-54. PubMed ID: 23507702
[TBL] [Abstract][Full Text] [Related]
3. Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells.
Sbiera S; Leich E; Liebisch G; Sbiera I; Schirbel A; Wiemer L; Matysik S; Eckhardt C; Gardill F; Gehl A; Kendl S; Weigand I; Bala M; Ronchi CL; Deutschbein T; Schmitz G; Rosenwald A; Allolio B; Fassnacht M; Kroiss M
Endocrinology; 2015 Nov; 156(11):3895-908. PubMed ID: 26305886
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of digoxin and ouabain on aldosterone synthesis in human adrenocortical NCI-H295 cells.
Kau MM; Kan SF; Wang JR; Wang PS
J Cell Physiol; 2005 Dec; 205(3):393-401. PubMed ID: 15887230
[TBL] [Abstract][Full Text] [Related]
5. Regulation of steroidogenesis in NCI-H295 cells: a cellular model of the human fetal adrenal.
Staels B; Hum DW; Miller WL
Mol Endocrinol; 1993 Mar; 7(3):423-33. PubMed ID: 8387159
[TBL] [Abstract][Full Text] [Related]
6. Leptin interferes with adrenocorticotropin/3',5'-cyclic adenosine monophosphate (cAMP) signaling, possibly through a Janus kinase 2-phosphatidylinositol 3-kinase/Akt-phosphodiesterase 3-cAMP pathway, to down-regulate cholesterol side-chain cleavage cytochrome P450 enzyme in human adrenocortical NCI-H295 cell line.
Hsu HT; Chang YC; Chiu YN; Liu CL; Chang KJ; Guo IC
J Clin Endocrinol Metab; 2006 Jul; 91(7):2761-9. PubMed ID: 16684834
[TBL] [Abstract][Full Text] [Related]
7. Effects of mitotane on gene expression in the adrenocortical cell line NCI-H295R: a microarray study.
Zsippai A; Szabó DR; Tömböl Z; Szabó PM; Eder K; Pállinger E; Gaillard RC; Patócs A; Tóth S; Falus A; Rácz K; Igaz P
Pharmacogenomics; 2012 Sep; 13(12):1351-61. PubMed ID: 22966885
[TBL] [Abstract][Full Text] [Related]
8. Modulation of proteomic profile in H295R adrenocortical cell line induced by mitotane.
Stigliano A; Cerquetti L; Borro M; Gentile G; Bucci B; Misiti S; Piergrossi P; Brunetti E; Simmaco M; Toscano V
Endocr Relat Cancer; 2008 Mar; 15(1):1-10. PubMed ID: 18310271
[TBL] [Abstract][Full Text] [Related]
9. Drug Synergism of Proteasome Inhibitors and Mitotane by Complementary Activation of ER Stress in Adrenocortical Carcinoma Cells.
Kroiss M; Sbiera S; Kendl S; Kurlbaum M; Fassnacht M
Horm Cancer; 2016 Dec; 7(5-6):345-355. PubMed ID: 27631436
[TBL] [Abstract][Full Text] [Related]
10. The effect of mitotane on viability, steroidogenesis and gene expression in NCI‑H295R adrenocortical cells.
Lehmann TP; Wrzesiński T; Jagodziński PP
Mol Med Rep; 2013 Mar; 7(3):893-900. PubMed ID: 23254310
[TBL] [Abstract][Full Text] [Related]
11. Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells.
Hescot S; Slama A; Lombès A; Paci A; Remy H; Leboulleux S; Chadarevian R; Trabado S; Amazit L; Young J; Baudin E; Lombès M
Endocr Relat Cancer; 2013 Jun; 20(3):371-81. PubMed ID: 23696597
[TBL] [Abstract][Full Text] [Related]
12. Steroidogenesis in the NCI-H295 Cell Line Model is Strongly Affected By Culture Conditions and Substrain.
Kurlbaum M; Sbiera S; Kendl S; Martin Fassnacht M; Kroiss M
Exp Clin Endocrinol Diabetes; 2020 Oct; 128(10):672-680. PubMed ID: 32349159
[TBL] [Abstract][Full Text] [Related]
13. Flavonoids exhibit diverse effects on CYP11B1 expression and cortisol synthesis.
Cheng LC; Li LA
Toxicol Appl Pharmacol; 2012 Feb; 258(3):343-50. PubMed ID: 22172629
[TBL] [Abstract][Full Text] [Related]
14. Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines.
Cerquetti L; Bucci B; Marchese R; Misiti S; De Paula U; Miceli R; Muleti A; Amendola D; Piergrossi P; Brunetti E; Toscano V; Stigliano A
Endocr Relat Cancer; 2008 Jun; 15(2):623-34. PubMed ID: 18509009
[TBL] [Abstract][Full Text] [Related]
15. Biphasic hormonal responses to the adrenocorticolytic DDT metabolite 3-methylsulfonyl-DDE in human cells.
Asp V; Ullerås E; Lindström V; Bergström U; Oskarsson A; Brandt I
Toxicol Appl Pharmacol; 2010 Feb; 242(3):281-9. PubMed ID: 19900470
[TBL] [Abstract][Full Text] [Related]
16. CREM confers cAMP responsiveness in human steroidogenic acute regulatory protein expression in NCI-H295R cells rather than SF-1/Ad4BP.
Sugawara T; Sakuragi N; Minakami H
J Endocrinol; 2006 Oct; 191(1):327-37. PubMed ID: 17065415
[TBL] [Abstract][Full Text] [Related]
17. Effects of ACTH and cAMP on steroidogenic acute regulatory protein and P450 11beta-hydroxylase messenger RNAs in rainbow trout interrenal cells: relationship with in vitro cortisol production.
Hagen IJ; Kusakabe M; Young G
Gen Comp Endocrinol; 2006 Feb; 145(3):254-62. PubMed ID: 16246334
[TBL] [Abstract][Full Text] [Related]
18. PCB126 induces differential changes in androgen, cortisol, and aldosterone biosynthesis in human adrenocortical H295R cells.
Li LA; Wang PW
Toxicol Sci; 2005 May; 85(1):530-40. PubMed ID: 15703266
[TBL] [Abstract][Full Text] [Related]
19. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line.
Borges KS; Andrade AF; Silveira VS; Marco Antonio DS; Vasconcelos EJR; Antonini SRR; Tone LG; Scrideli CA
Anticancer Drugs; 2017 Jul; 28(6):634-644. PubMed ID: 28410270
[TBL] [Abstract][Full Text] [Related]
20. CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells.
Germano A; Saba L; De Francia S; Rapa I; Perotti P; Berruti A; Volante M; Terzolo M
PLoS One; 2018; 13(5):e0196931. PubMed ID: 29734384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]